This case uses albumin-binding FN3 domains fused to therapeutics to extend half-life, reduce renal clearance, and limit frequent dosing.
Heating fibroin with lithium bromide at elevated pressure alters its composition, helping aqueous solutions resist aggregation and gelation.
This case links human type III collagen to viral antigens, using a linker and disulfide bonds for stable trimers and focused immunity.
This case uses enzymatic dermis washing, homogenization, extraction, and separation to produce collagen with tailored durability.
Replace costly Matrigel and protein functionalization with customizable fungus-yeast biocapsules that support uniform tissue growth.
Learn how 5–40 μm fragmented ECM particles reinforce bioink while preserving smooth ejection for robust tissue structures.
This case uses anti-CTHRC1 antibodies to block adhesion, enable internalization, and increase CD8+ T-cell infiltration.
This case uses CTHRC1 binding to deliver T-cell costimulation in tumor regions, addressing stromal suppression and systemic toxicity.